![Frontiers | Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL) Frontiers | Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)](https://www.frontiersin.org/files/Articles/625414/fgene-12-625414-HTML/image_m/fgene-12-625414-g001.jpg)
Frontiers | Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
![PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40033686/mini_magick20190222-21889-1hme795.png?1550825548)
PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu
![Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/225498/f/1.png)
Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2016.92/MediaObjects/41379_2016_Article_BFmodpathol201692_Fig1_HTML.jpg)
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies | PLOS ONE
![Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021 Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021](https://journals.sagepub.com/cms/10.1177/20406207211013987/asset/images/large/10.1177_20406207211013987-fig2.jpeg)
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
![Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021 Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021](https://journals.sagepub.com/cms/10.1177/20406207211013987/asset/images/large/10.1177_20406207211013987-fig3.jpeg)
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
![Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2016.92/MediaObjects/41379_2016_Article_BFmodpathol201692_Fig6_HTML.jpg)
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
![Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine](https://www.thelancet.com/cms/attachment/b2bb435b-74bf-4d4d-91e9-0bab8a36895b/gr1_lrg.jpg)
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine
![Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma. - Abstract - Europe PMC Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3629761/bin/10.1177_2040620712464508-fig1.jpg)
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma. - Abstract - Europe PMC
![JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact](https://pub.mdpi-res.com/jcm/jcm-08-01074/article_deploy/html/images/jcm-08-01074-ag.png?1564598768)
JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
![Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/de85ec9b-1453-445a-b180-d1874c741c17/bjh.v196.4.cover.jpg?trick=1673096986327)
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library
![Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies](https://www.frontiersin.org/files/Articles/426970/fonc-08-00556-HTML/image_m/fonc-08-00556-g001.jpg)